Edward Pesicka - Owens Minor President, Chief Executive Officer, Director
OMI Stock | USD 13.47 0.16 1.20% |
CEO
Mr. Edward A. Pesicka is President, Chief Executive Officer, Director of the company, since march 04, 2019. He was named the President and Chief Executive Officer of Owens Minor, Inc. and elected to the Board on March 7, 2019. Previously he served as an independent consultant and advisor in the healthcare, life sciences and distribution industries since January 1, 2016. From January 2000 through April 2015, Mr. Pesicka served in various roles of increasing responsibility at Thermo Fisher Scientific Inc., including, most recently, Chief Commercial Officer and Senior Vice President from January 2014 to April 2015. Prior to that, he was President, Customer Channels at Thermo Fisher from July 2008 to January 2014 and President, Research Market from November 2006 to July 2008. Earlier in his career, Mr. Pesicka held various Vice Presidentlevel roles in Thermo Fischer Scientifics finance department, serving as Chief Financial Officer of numerous divisions. Prior to Thermo Fisher Scientific, Mr. Pesicka spent eight years with TRW, Inc. in its finance department and three years with PricewaterhouseCoopers as an auditor. since 2019.
Age | 56 |
Tenure | 5 years |
Address | 9120 Lockwood Boulevard, Mechanicsville, VA, United States, 23116 |
Phone | 804 723 7000 |
Web | https://www.owens-minor.com |
Edward Pesicka Latest Insider Activity
Tracking and analyzing the buying and selling activities of Edward Pesicka against Owens Minor stock is an integral part of due diligence when investing in Owens Minor. Edward Pesicka insider activity provides valuable insight into whether Owens Minor is net buyers or sellers over its current business cycle. Note, Owens Minor insiders must abide by specific rules, including filing SEC forms every time they buy or sell Owens Minor'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Edward Pesicka over six months ago Disposition of 58126 shares by Edward Pesicka of Owens Minor at 24.99 subject to Rule 16b-3 |
Owens Minor Management Efficiency
The company has Return on Asset of 0.0402 % which means that on every $100 spent on assets, it made $0.0402 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.0554) %, meaning that it generated no profit with money invested by stockholders. Owens Minor's management efficiency ratios could be used to measure how well Owens Minor manages its routine affairs as well as how well it operates its assets and liabilities. The Owens Minor's current Return On Tangible Assets is estimated to increase to -0.01. The current Return On Capital Employed is estimated to decrease to 0.03. As of now, Owens Minor's Intangible Assets are increasing as compared to previous years. The Owens Minor's current Other Assets is estimated to increase to about 181.6 M, while Other Current Assets are projected to decrease to under 92.6 M.Similar Executives
Found 7 records | CEO Age | ||
Donald Zurbay | Patterson Companies | 56 | |
Stanley CPA | Henry Schein | 74 | |
Brian Tyler | McKesson | 57 | |
Michael Kaufmann | Cardinal Health | 58 | |
James Breslawski | Henry Schein | 70 | |
Victor Crawford | Cardinal Health | 59 | |
Stephen Mason | Cardinal Health | 53 |
Management Performance
Return On Equity | -0.0554 | ||||
Return On Asset | 0.0402 |
Owens Minor Leadership Team
Elected by the shareholders, the Owens Minor's board of directors comprises two types of representatives: Owens Minor inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Owens. The board's role is to monitor Owens Minor's management team and ensure that shareholders' interests are well served. Owens Minor's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Owens Minor's outside directors are responsible for providing unbiased perspectives on the board's policies.
Christopher Lowery, President - Global Products | ||
Snehashish Sarkar, Executive Officer | ||
Jennifer Stone, Executive Officer | ||
Alex CPA, Director Relations | ||
Jeffrey Jochims, Executive Vice President, Chief Operating Officer, President - Products and Healthcare Services | ||
Shana Neal, Chief Human Resource Officer, Executive Vice President | ||
Aster Angagaw, Independent Director | ||
Tammy Gomez, Ex Officer | ||
Michael Riordan, Independent Director | ||
Trudi Allcott, Director Relations | ||
Stephen Klemash, Independent Director | ||
Edward Pesicka, President, Chief Executive Officer, Director | ||
Michael Lowry, Interim Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Corporate Controller | ||
Robert Henkel, Independent Director | ||
Gwendolyn Bingham, Independent Director | ||
Alexander Bruni, Executive Officer | ||
Kenneth Smith, Independent Director | ||
Andrew Long, Chief Financial Officer, Executive Vice President | ||
Daniel Starck, Executive Excellence | ||
Mark Zacur, Executive Vice President, Chief Commercial Officer | ||
Heath Galloway, General VP | ||
Robert Sledd, Independent Chairman of the Board | ||
Jonathan Leon, Senior Vice President Corporate Treasurer | ||
Eddie Moore, Independent Director | ||
Kenny Gardner, Director | ||
David Myers, Senior Vice President Chief Procurement Officer | ||
Mark Beck, Independent Chairman of the Board | ||
Nicholas II, Gen VP | ||
Nicholas Pace, Executive Vice President, General Counsel, Corporate Secretary | ||
Perry Bernocchi, Executive Segment | ||
Mark McGettrick, Independent Director |
Owens Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Owens Minor a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.0554 | ||||
Return On Asset | 0.0402 | ||||
Profit Margin | (0) % | ||||
Operating Margin | 0.02 % | ||||
Current Valuation | 3.15 B | ||||
Shares Outstanding | 77.11 M | ||||
Shares Owned By Insiders | 2.43 % | ||||
Shares Owned By Institutions | 97.57 % | ||||
Number Of Shares Shorted | 3.57 M | ||||
Price To Earning | 42.00 X |
Currently Active Assets on Macroaxis
When determining whether Owens Minor offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Owens Minor's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Owens Minor Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Owens Minor Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Owens Minor. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For more detail on how to invest in Owens Stock please use our How to Invest in Owens Minor guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Owens Minor. If investors know Owens will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Owens Minor listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.72) | Earnings Share (0.63) | Revenue Per Share 139.342 | Quarterly Revenue Growth 0.05 | Return On Assets 0.0402 |
The market value of Owens Minor is measured differently than its book value, which is the value of Owens that is recorded on the company's balance sheet. Investors also form their own opinion of Owens Minor's value that differs from its market value or its book value, called intrinsic value, which is Owens Minor's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Owens Minor's market value can be influenced by many factors that don't directly affect Owens Minor's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Owens Minor's value and its price as these two are different measures arrived at by different means. Investors typically determine if Owens Minor is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Owens Minor's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.